Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 30, 2017

DrugPatentWatch Database Preview

DESMOPRESSIN ACETATE Drug Profile

« Back to Dashboard

Which patents cover Desmopressin Acetate, and when can generic versions of Desmopressin Acetate launch?

Desmopressin Acetate is a drug marketed by Sun Pharm Inds, Apotex Inc, Hospira, Impax Labs Inc, Bausch And Lomb, Glenmark Pharms Ltd, Mylan Pharms Inc, Actavis Labs Fl Inc, Bedford, Sun Pharm Inds Ltd, Teva Pharms Usa, Ferring, and Sun Pharma Global. and is included in fifteen NDAs.

The generic ingredient in DESMOPRESSIN ACETATE is desmopressin acetate. There are nineteen drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the desmopressin acetate profile page.

Summary for Tradename: DESMOPRESSIN ACETATE

Patents:0
Applicants:13
NDAs:15
Suppliers / Packagers: see list18
Bulk Api Vendors: see list54
Clinical Trials: see list471
Patent Applications: see list3,036
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DESMOPRESSIN ACETATE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds
DESMOPRESSIN ACETATE
desmopressin acetate
SOLUTION;NASAL077212-001Apr 12, 2012ABRXNoNo► Subscribe► Subscribe
Ferring
DESMOPRESSIN ACETATE
desmopressin acetate
TABLET;ORAL021795-002May 8, 2008DISCNNoNo► Subscribe► Subscribe
Bausch And Lomb
DESMOPRESSIN ACETATE
desmopressin acetate
SPRAY, METERED;NASAL074830-001Jan 25, 1999ABRXNoYes► Subscribe► Subscribe
Hospira
DESMOPRESSIN ACETATE
desmopressin acetate
INJECTABLE;INJECTION075220-001Aug 28, 2000APRXNoNo► Subscribe► Subscribe
Actavis Labs Fl Inc
DESMOPRESSIN ACETATE
desmopressin acetate
TABLET;ORAL076470-001Jul 1, 2005ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Predict branded drug patent expiration
  • Drug patents and clinical trials in dozens of countries
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot